Accesso libero

ROLE OF THE CYP1A2 GENE POLYMORPHISM ON EARLY AGEING FROM OCCUPATIONAL EXPOSURE

INFORMAZIONI SU QUESTO ARTICOLO

1. Vijg J. Somatic mutations and aging: a re-evaluation. Mutat Res. 2000; 447(1): 117-135.10.1016/S0027-5107(99)00202-XSearch in Google Scholar

2. Wojda A, Witt M. Manifestations of aging at the cytogenetic level. J Appl Genet. 2003; 44(3): 383-399.Search in Google Scholar

3. Harman D. The aging process: major risk factor for disease and death. Proc Nat Acad Sci USA. 1991; 88(12): 5360-5363.10.1073/pnas.88.12.5360518722052612Search in Google Scholar

4. Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, et al. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colo-rectal cancer in Lynch Syndrome. Cancer Epidemiol Bio-markers Prev. 2008; 17(9): 2393-2399.10.1158/1055-9965.EPI-08-0326302853218768509Search in Google Scholar

5. Lautraite S, Musonda AC, Doehmer J, Edwards GO, Chipman JK. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis. 2002; 17(1): 45-53.10.1093/mutage/17.1.4511752233Search in Google Scholar

6. Al Zabadi H, Ferrari L, Laurent AM, Tiberguent A, Paris C, Zmirou-Navier D. Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris. BMC Cancer. 2008; 8(1): 67-77.10.1186/1471-2407-8-67229219918325085Search in Google Scholar

7. Vainio H. Use of biomarkers in risk assessment. Int J Hyg Environ Health. 2001; 204(2-3): 91-102.10.1078/1438-4639-0008811759167Search in Google Scholar

8. Martino-Roth MG, Viegas J, Amaral M, Oliveira L, Ferreira FLS, Erdtmann B. Evaluation of genotoxicity through micronuclei test in workers of car and battery repair garages. Genet Mol Biol. 2002; 25(4): 495-500.10.1590/S1415-47572002000400021Search in Google Scholar

9. Eshkoor SA, Ismail P, Rahman SA, Moin S. Does GSTP1 polymorphism contribute to genetic damage caused by ageing and occupational exposure? Arh Hig Rada Toksikol. 2011; 62(4): 291-298.10.2478/10004-1254-62-2011-208822202462Search in Google Scholar

10. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10): e47.10.1093/nar/30.10.e4711530112000852Search in Google Scholar

11. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5’-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem. 1999; 125(4): 803-808.10.1093/oxfordjournals.jbchem.a02235210101295Search in Google Scholar

12. Pavanello S, Pulliero A, Lupi S, Gregorio P, Clonfero E. Influence of the genetic polymorphism in the 5’-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res. 2005; 587(1-2): 59-66.10.1016/j.mrgentox.2005.08.00816188490Search in Google Scholar

13. Hashizumea T, Yoshitomia S, Asahia S, Matsumuraa S, Chatania F, Odab H. In vitro micronucleus test in HepG2 transformants expressing a series of human cyto-chrome P450 isoforms with chemicals requiring metabolic activation. Mutat Res. 2009; 677(1-2): 1-7.10.1016/j.mrgentox.2009.03.00919501186Search in Google Scholar

14. da Silva J, Moraes CR, Heuser VD, Andrade VM, Silva FR, Kvitko K, et al. Evaluation of genetic damage in a Brazilian population occupationally exposed to pesticides and its correlation with polymorphisms in metabolizing genes. Mutagenesis. 2008; 23(5): 415-422.10.1093/mutage/gen03118550589Search in Google Scholar

15. Castorena-Torres F, Mendoza-Cantu A, de Leon MB, Cisneros B, Zapata-Perez O, López-Carrillo L, et al. CYP1A2 phenotype and genotype in a population from the carboniferous region of Coahuila, Mexico. Toxicol Lett. 2005; 156(3): 331-339.10.1016/j.toxlet.2004.12.00515763632Search in Google Scholar

16. Bageman E, Ingvar C, Rose C, Jernstrom H. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev. 2008; 17(4): 895-901.10.1158/1055-9965.EPI-07-055518398030Search in Google Scholar

17. Iba MM, Fung J. Pulmonary CYP1A1 and CYP1A2 levels and activities in adult male and female offspring of rats exposed during gestation and lactation to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol. 2001; 62(5): 617-626.Search in Google Scholar

18. Sata F, Yamada H, Suzuki K, Saijo Y, Kato EH, Morikawa M, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod. 2005; 11(5): 357-360.10.1093/molehr/gah17515849225Search in Google Scholar

19. Kirsch-Volders M, Mateuca RA, Roelants M, Tremp A, Zeiger E, Bonassi S, et al. The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epi-demiol Biomarkers Prev. 2006; 15(5): 1038-1042.10.1158/1055-9965.EPI-05-048716702390Search in Google Scholar

20. Garte S, Taioli E, Popov T, Kalina I, Sram R, Farmer P. Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans. Int J Cancer. 2006; 120(11): 2499-2503.10.1002/ijc.2247717330842Search in Google Scholar

21. Palma S, Cornetta T, Padua L, Cozzi R, Appolloni M, Ievoli E, et al. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res. 2007; 633(1): 1-12.10.1016/j.mrgentox.2007.03.01417644396Search in Google Scholar

22. Zhan P, Wang J, Zhang Y, Qiu LX, Zhao SF, Qian Q, et al. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer. 2010; 69(1): 19-25.10.1016/j.lungcan.2009.09.00119796841Search in Google Scholar

23. Pinto D, Ceballos JM, Garcia G, Guzman P, Del Razo LM, Vera E, et al. Increased cytogenetic damage in outdoor painters. Mutat Res. 2000; 467(2): 105-111.10.1016/S1383-5718(00)00024-3Search in Google Scholar

24. Manikantan P, Balachandar V, Sasikala K. DNA Damage in workers occupationally exposed to lead, using comet assay. Int J Biol. 2010; 2(1): 103-110. 10.5539/ijb.v2n1p103Search in Google Scholar

ISSN:
1311-0160
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicine, Basic Medical Science, other